Brandywine Global Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Brandywine Global Investment Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-32,657	Closed	-$497K	–	908
2018 Q4	$497K	Sell	32,657 -12,101	-27%	-$231K	﹤0.01%	565
2018 Q3	$896K	Buy	44,758 +87	+0.2%	+$1.98K	0.01%	573
2018 Q2	$872K	Sell	44,671 -1,117	-2%	-$24.7K	0.01%	592
2018 Q1	$923K	Sell	45,788 -14,591	-24%	-$247K	0.01%	585
2017 Q4	$801K	Sell	60,379 -9,871	-14%	-$149K	﹤0.01%	594
2017 Q3	$1.3M	Buy	+70,250	New	+$1.31M	0.01%	575
2017 Q2	–	Sell	-11,390	Closed	-$257K	–	961
2017 Q1	$257K	Buy	+11,390	New	+$273K	﹤0.01%	677

Other funds holding AMAG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Brandywine Global Investment Management's AMAG Position: Q1 2019 in Review

Brandywine Global Investment Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 32,657 shares — an estimated $497K sold.

Brandywine Global Investment Management first reported a position in AMAG in Q1 2017 and held it in 7 quarters. The position peaked at $1.3M in Q3 2017. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

Brandywine Global Investment Management reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Brandywine Global Investment Management sold 32,657 AMAG Pharmaceuticals shares in Q1 2019, an estimated $497K.
Brandywine Global Investment Management first reported a position in AMAG Pharmaceuticals in Q1 2017 and held it in 7 quarters.
Brandywine Global Investment Management's AMAG Pharmaceuticals position peaked at $1.3M in Q3 2017.
166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on Brandywine Global Investment Management's 13F filing for Q1 2019, filed 15 May 2019.